• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性蛋白 C 缺陷的日本男性患者使用直接口服抗凝剂治疗复发性脑静脉血栓形成。

Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japanese Man with Hereditary Protein C Deficiency.

机构信息

Department of Neurology, Nissan Tamagawa Hospital, Seta 4-8-1, Setagaya, Tokyo 158-0095, Japan.

Department of Emergency, Nissan Tamagawa Hospital, Setagaya, Tokyo, Japan.

出版信息

J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105320. doi: 10.1016/j.jstrokecerebrovasdis.2020.105320. Epub 2020 Oct 31.

DOI:10.1016/j.jstrokecerebrovasdis.2020.105320
PMID:33131982
Abstract

We herein report a case involving a 32-year-old Japanese man with recurrent cerebral venous thrombosis due to hereditary protein C deficiency. He was admitted to our hospital with impaired consciousness. Brain magnetic resonance imaging demonstrated high intensities diffusely along the bilateral sulci and magnetic resonance venography revealed left transverse sinus and superior sagittal sinus stenoses. His father had a history of cerebral infarction and venous thrombosis. The protein C activity level examined by chromogenic synthetic substrate assay was markedly reduced. He was diagnosed with protein C deficiency, and a genetic analysis revealed a heterozygous mutation at exon 3 c.199G>A,p.Glu67Lys on the protein C gene. Four months later, at his second admission, he had transient aphasia, and his protein C activity was under 10%. We switched warfarin to the direct oral anticoagulants edoxaban. He remains fully recovered with no adverse events after the administration of edoxaban for a year. Direct oral anticoagulants may be a new tool for treating cerebral venous thrombosis due to hereditary protein C deficiency.

摘要

我们在此报告一例因遗传性蛋白 C 缺乏导致复发性脑静脉血栓形成的 32 岁日本男性患者。他因意识障碍而入院。脑磁共振成像显示双侧脑沟弥漫性高信号,磁共振静脉造影显示左侧横窦和上矢状窦狭窄。他的父亲有脑梗死和静脉血栓形成病史。色原性合成底物检测法检测的蛋白 C 活性水平显著降低。他被诊断为蛋白 C 缺乏症,基因分析显示蛋白 C 基因外显子 3 c.199G>A,p.Glu67Lys 杂合突变。四个月后,他第二次入院时出现短暂性失语,蛋白 C 活性低于 10%。我们将华法林转换为直接口服抗凝剂依度沙班。依度沙班治疗一年后,他完全恢复,无不良事件发生。直接口服抗凝剂可能成为治疗遗传性蛋白 C 缺乏引起的脑静脉血栓形成的新方法。

相似文献

1
Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japanese Man with Hereditary Protein C Deficiency.遗传性蛋白 C 缺陷的日本男性患者使用直接口服抗凝剂治疗复发性脑静脉血栓形成。
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105320. doi: 10.1016/j.jstrokecerebrovasdis.2020.105320. Epub 2020 Oct 31.
2
[A case of recurrent cerebral vein thrombosis with protein C gene mutation identified].[一例伴有蛋白C基因突变的复发性脑静脉血栓形成病例]
Rinsho Shinkeigaku. 2018 Dec 21;58(12):764-766. doi: 10.5692/clinicalneurol.cn-001221. Epub 2018 Nov 29.
3
Clinical Trial Based Rationale for the Successful Use of DOAC in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A Case Report.基于临床试验的直接口服抗凝剂成功用于治疗脑静脉窦血栓形成(CVST)的理论依据:病例报告
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105261. doi: 10.1016/j.jstrokecerebrovasdis.2020.105261. Epub 2020 Sep 3.
4
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.磁共振静脉造影评估依度沙班单药治疗与胃肠外抗凝/华法林治疗对有症状的深静脉血栓形成患者血栓溶解情况的对比:一项多中心可行性研究。
Vasc Med. 2016 Aug;21(4):361-8. doi: 10.1177/1358863X16645853. Epub 2016 May 10.
5
Recurrent Hemorrhagic Venous Infarctions Caused by Thrombosis of a Pontine Developmental Venous Anomaly and Protein S Mutation.脑桥发育性静脉异常血栓形成及蛋白S突变所致复发性出血性静脉梗死
J Stroke Cerebrovasc Dis. 2016 Nov;25(11):e216-e217. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.040. Epub 2016 Sep 19.
6
Protein C concentrates in a neonate with a cerebral venous thrombosis due to heterozygous type 1 protein C deficiency.因杂合子1型蛋白C缺乏症导致脑静脉血栓形成的新生儿使用蛋白C浓缩物治疗。
Thromb Haemost. 2001 Jun;85(6):1118-9.
7
[Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban].
Nihon Yakurigaku Zasshi. 2010 Aug;136(2):83-7. doi: 10.1254/fpj.136.83.
8
Deep Venous Thrombosis with Decreased Cerebral Blood Flow to the Thalamus was Completely Restored by Factor Xa Inhibitor.Xa因子抑制剂完全恢复了伴有丘脑脑血流量减少的深静脉血栓形成。
J Stroke Cerebrovasc Dis. 2019 May;28(5):e39-e43. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.023. Epub 2019 Feb 14.
9
Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.在大鼠中通过单次和多次给药使用口服直接Xa因子抑制剂依度沙班治疗静脉血栓形成。
Eur J Pharmacol. 2014 Nov 5;742:15-21. doi: 10.1016/j.ejphar.2014.08.020. Epub 2014 Aug 30.
10
Pathogenic variants of PROC gene caused type II activity deficiency in a Chinese family: A case report.PROC基因的致病变异导致一个中国家系出现II型活性缺乏:病例报告
Medicine (Baltimore). 2021 Mar 26;100(12):e25160. doi: 10.1097/MD.0000000000025160.

引用本文的文献

1
Efficacy and safety of direct oral anticoagulants in patients with venous thrombosis and inherited thrombophilia.直接口服抗凝剂在静脉血栓形成和遗传性血栓形成倾向患者中的疗效和安全性。
Int J Med Sci. 2025 Jun 23;22(13):3182-3190. doi: 10.7150/ijms.108258. eCollection 2025.
2
An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series.伴有遗传性蛋白C/S缺乏的急性/亚急性重症脑静脉血栓形成的抗炎治疗探索:病例系列
J Inflamm Res. 2023 Nov 21;16:5403-5415. doi: 10.2147/JIR.S428589. eCollection 2023.
3
Inherited Thrombophilia in the Era of Direct Oral Anticoagulants.
直接口服抗凝剂时代的遗传性血栓形成倾向。
Int J Mol Sci. 2022 Feb 5;23(3):1821. doi: 10.3390/ijms23031821.
4
A Case of Treatment With Dabigatran for Cerebral Venous Thrombosis Caused by Hereditary Protein C Deficiency.1例遗传性蛋白C缺乏所致脑静脉血栓形成的达比加群治疗病例
Cureus. 2021 Jun 6;13(6):e15473. doi: 10.7759/cureus.15473. eCollection 2021 Jun.
5
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.直接口服抗凝剂治疗脑静脉血栓形成:系统评价。
BMJ Open. 2021 Feb 16;11(2):e040212. doi: 10.1136/bmjopen-2020-040212.